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Maintenance of intracellular Ca2+ levels at orders of magnitude below those in the extracellular environment is a requisite
for preserving cell viability. Membrane channels contribute to such control through modulating their time-dependent
opening and closing behaviour. Such regulation requires Ca2+ to serve as a second messenger mediating receptor control
of numerous life-sustaining responses. Transient receptor potential (TRP) channels signal transduce a wide variety of
different sensory stimuli to induce responses modulating cellular function. These channels are non-selective cation
channels with variable Ca2+ selectivity having extensive sequence homology. They constitute a superfamily made up of
28 different members that are subdivided into 7 different subfamilies based on differences in sequence homology. Some
of these TRP channel isotypes are expressed in the eye and localized to both neuronal and non-neuronal cell membranes.
Their activation generates intracellular Ca2+ transients and other downstream-linked signalling events that affect numerous
responses required for visual function. As there is an association between changes in functional TRP expression in various
ocular diseases, there are efforts underway to determine if these channels can be used as drug targets to reverse declines
in ocular function. We review here our current knowledge about the expression, function and regulation of TRPs in
different eye tissues in health and disease. Furthermore, some of the remaining hurdles are described to developing safe
and efficacious TRP channel modulators for use in a clinical setting.
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TRP channel relevance to ocular function
One of the reasons why ocular transient receptor potential
(TRP) channels are essential for maintaining normal vision is
that some of their subtypes transduce environmental stresses
into cell signalling events to control different physiological
responses that alter cellular function. This realization has
prompted intense research efforts to more extensively
characterize how they control responses countering losses in
cellular function caused by tissue injury, touch, fluctuations
in ambient temperature, pH as well as osmolarity, hormonal
exposure and pathogen tissue infiltration. Such insights can
lead to the identification of lead compounds whose develop-
ment may provide novel agents for improving the treatment
of different ocular diseases in a clinical setting.
Functional TRP expression has been identified in every
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unless otherwise stated.stimuli under both physiological and pathophysiological con-
ditions. By virtue of their non-selective cation permeability,
their activation elicits intracellular Ca2+ transients ultimately
triggering pain, scarring and inflammation to these various
environmental activators [1,2]. There is heightening interest
by drug companies in screening pipeline compounds target-
ing different ocular TRP channel subtypes because some of
them are promising targets for reversing pathophysiological
changes that compromise ocular function. For example, in
different animal models of hypertensive glaucoma and
injury-induced cornea scarring, declines in TRP function
are associated with reductions in excitotoxic-induced ret-
inal ganglion cell (RGC) dysfunction and corneal stromal fi-
brosis [3-5]. On the other hand, implying that suppressing
TRP activation has therapeutic potential in glaucoma may
be premature because of a concern about this model’s
physiological relevance [1]. Another concern regarding the
role of changes in functional TRP expression to visual pro-
cessing stems from a more recent study showing that loss
of TRP function instead inhibits optic nerve function [6].
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nists is the preferred approach for effectively treating glau-
coma. This caveat prompts studies to unravel complexities
of TRP channel involvement in ocular function. To shed
some light on this complex question, we review literature
describing ocular TRP channel functional expression in the
cornea, conjunctival epithelium, uvea, lens and retina. In
addition, the possible association between TRP channel
mutations and some ocular diseases is considered.
Review
TRP channel nomenclature and channelopathies
Studies on Drosophila retinal phototransduction were
the driving force for subsequent work on TRP channels.
In the initial report, a mutant blind strain was identified
in which a light flash elicited an aberrant transient rather
than sustained retinal membrane depolarization [7].
Subsequently, it was realized that the channel eliciting
this altered response has a homology with TRP channels.
The TRP prototype was cDNA cloned from sensory neu-
rons and functionally expressed nearly 30 years later [8].
This cloned channel is the forerunner of all subsequently
identified TRP isoforms. Early on, it was referred to as
the capsaicin receptor since this red pepper extract con-
stituent is an agonist of this channel. This prototype has
sequence homology with 28 different subtypes that to-
gether constitute a TRP superfamily [9,10]. In the TRP
classification scheme, it is designated as TRP vanilloid 1
(TRPV1). All superfamily members assemble as tetra-
mers and have a common configuration: six transmem-
brane spanning units in which the span between the
fifth and sixth segments forms a conduit for cation
membrane permeation. This superfamily is separated
into seven different subfamilies and includes: a) TRPA
(ankyrin); b) TRPC1-4 (canonical); c) TRPM 1–8 (mela-
statin); d) TRPML (mucolipin); e) TRPN (no mechano-
potential); f ) TRPP (polycystin); g) TRPV1-7 (vanilloid)
[11]. Drosophila phototransduction is mediated by a
TRPC channel together with a second TRPC channel,
trp-like (TRPL) [12]. The relevance of defining TRP
channel subtypes and their function is now more appar-
ent since changes in their protein expression and func-
tion underlie either many hereditary diseases (so-called
TRP channelopathies) or contribute indirectly to the
genesis of several diseases including cancer [13-15].
TRP activation overview
TRP channels are cellular sensors involved in the forma-
tion of sight, hearing, touch, smell, taste, temperature,
and pain sensation. These diverse TRP functions are
elicited through activation of downstream cell signalling
pathways and allow the host cell to respond to benign or
harmful environmental changes. The molecular mecha-
nisms underlying TRP channel activation are verycomplex and not yet fully understood. TRP activation is
caused by an increase in channel open time, which can
be prolonged by a host of different factors. For example,
changes in membrane stretch and exposure to an anisos-
motic challenge (such as TRPV1 and TRPV4) as well as
kinase-induced channel phosphorylation all lead to TRP
activation whereas cooling directly can activate TRPM8
[16-18]. Another type of activation of TRPs occurs via
more or less specific ligands. Initially, it was realized that
either exogenous small organic synthetic compounds or
natural products could activate TRPs. Even though
TRPV1 was originally designated as the capsaicin recep-
tor, subsequent studies revealed that it also interacts
with other TRP isoforms. This red pepper extract con-
stituent also activates voltage-gated inward and outward
currents as well as impairs mitochondrial function and
inhibits prostaglandin E2 production through non
TRPV1 pathways [1]. There are indications in the retina
that it may also activate TRPM1 channels. In addition,
there may be other sites of interaction since in TRPM1
−/− mice; the responses to capsaicin were not fully atten-
uated. Other (synthetic) agonists are icilin (TRPM8),
which was also described as a super cooling agent [19]
or camphor (TRPV3) [20,21]. Furthermore, endogenous
lipids or products of lipid metabolism are also ligands of
TRPs. Finally, inorganic ions such as Ca2+ or Mg2+ can
also (directly) activate TRPs (e.g. TRPM6 for Mg2+ [22] or
TRPA1 for Ca2+ [23]). However, it is not yet known if the
TRP conformational changes induced by Ca2+ or Mg2+ are
the same as those induced by a thermal transition known
to activate these different TRP channel subtypes.
Overall, classical activation of TRPs and in particular
thermo-TRPs are mostly related to direct activation via
mechanical stimuli or channel phosphorylation or cer-
tain exogenous and endogenous agents or inorganic
ions. Given the complexities in identifying selective TRP
channel modifiers, any drug target assignment should be
verified by determining if a drug-induced response can
be mimicked in transgenic mice having either a selective
TRP gain or loss of function. If a drug effect cannot be
replicated, it is possible that it will instead be caused by
a compensatory response provided by modulation of an-
other TRP subtype leaving drug selectivity uncertain.
Reciprocal TRP channel and G-protein coupled receptor
activation
G-protein-coupled receptors (GPCRs) and TRP channels
are coexpressed on sensory neurons and act as sensors
of noxious irritants and inflammatory stimulants. With
approximately 850 GPCR variants in mammals, they are
the largest family of signalling proteins. Due to their
responsiveness to the largest group of diverse structural
ligands, 30% of current drugs target GPCRs to treat
pathophysiological conditions. More than 40 GPCR
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sensors on peripheral nerves to detect noxious, irritant,
and inflammatory stimuli, including proteases, peptides,
amines, and lipids [24]. Sensory nerves express TRP
channels, which directly sense endogenous and exogen-
ous chemical, mechanical, and thermal stimuli. These
nonselective cation channels are also major downstream
effectors of GPCR signalling. This GPCR-TRP axis is re-
sponsible for eliciting pain, itch, cough, and neurogenic
inflammation [25-27]. Signalling pathways that emanate
from the GPCR superfamily lead to altered TRP channel
activity or expression. GPCR signalling can generate me-
diators that stimulate TRP channels (i.e., channel activa-
tion) or instead enhance their responses to TRP agonists
(i.e., TRP sensitization). For example, TRPV1 activity can
be modulated by a wide variety of endogenous small mole-
cules through different regulatory mechanisms that either
increase or decrease its sensitivity to different conditions
known to either stimulate or inhibit this channel. In one
case, TRP channels can amplify GPCR effects and mediate
their contributions to transmission of pain, itch, cough,
and neurogenic inflammation. Conversely, GPCR activa-
tion can generate mediators that stimulate TRP channels
(i.e., channel activation) or that enhance their responses to
TRP agonists (i.e., TRP sensitization). The net result is that
TRP channels can amplify the effects of GPCRs and medi-
ate their contributions to transmission of pain, itch, cough,
and neurogenic inflammation [28].
Dependence of TRP channel-induced phototransduction
on GPCR activation
The mutant channel accounting for the aforementioned
aberrant phototransduction response in the blind Dros-
ophila strain was found in later studies to have a so-
called TRP box structural sequence. This sequence is
common to all TRPs including TRPV1, the founding
member of the TRP superfamily. This 28-member
superfamily forms the basis of receptor-operated TRP
channel gating across species. In the plasma membrane
of Drosophila photoreceptors, the receptor-operated
channel activity requires GPCR activation and release of a
heterotrimeric GTP bound G-protein complex, phospho-
lipase C activity, and metabolism of phospholipids and
phosphotidyl inositol-4,5 bisphosphate (PIP2) leading to
the generation of inositol trisphosphate (IP3), membrane-
associated diacylglycerol (DAG) and arachidonic acid. IP3
binds to its receptor on intracellular stores to release Ca2+
from intracellular stores (ICS) and DAG stimulates kinase
activity. Ca2+ losses leading to the activation of store-
operated Ca2+ channels (SOCs) are composed of TRP sub-
units such as TRPC1 and TRPC4 [29]. SOC activation
results in the refilling of the depleted ICS. Although the
mechanism is still not clear, the activation threshold for
TRP channel activation is lowered (i.e. sensitized) by theinflux of Ca2+ and fatty acid second messengers to permit
channel opening leading to light-induced current and
membrane depolarization. This process is desensitized by
DAG-sensitive kinase phosphorylation of the TRP channel
and the Ca2+ sensitive protein calmodulin (CaM), which
binds to the channel preventing channel reactivation [30].Thermosensitive TRP channel activation
The ability to sense environmental temperatures and
to avoid noxious heat or cold is crucial for the survival
of all organisms. Six different thermosensitive TRP iso-
types provide such protection in different ocular tis-
sues. For TRPV1-4 [31] and TRPM8/TRPA1 [32-34]
their activity is temperature sensitive within specific
ranges. TRPV1-4 as well as TRPM8 and TRPA1 sensi-
tivities span almost the entire temperature range to
which mammals are exposed. In the vanilloid subfam-
ily, TRPV4 and TRPV3 are activated by temperatures
from 25 to 31°C, respectively, whereas TRPV1 is acti-
vated at 43°C and TRPV2 at a noxious temperature of
51°C [35]. On the other hand, TRPM8 and TRPA1 are
activated below 25 and 17°C, respectively. The mech-
anism(s) underlying these different temperature sensi-
tivities are poorly understood.
Three hypothetical mechanisms may account for the
origin of these remarkably steep temperature sensitiv-
ities. They include: 1) steep specific temperature depend-
ence for ligand binding; 2) temperature-induced channel
rearrangement; 3) temperature-dependent membrane
tension changes may lead to channel opening [31]. A re-
cent report suggests that differences in TRP channel
protein sequence endow thermal sensitivity, which could
mean that this property is ascribable to specific struc-
tural changes. This suggestion stems from the finding
that in the Drosophila TRPA1 isoform, thermal sensitiv-
ity variability is linked to changes in the expression of a
specific 37-amino-acid long intracellular region (encoded
by a single exon) [36]. TRPM8 stimulation could result
in graded shifts of voltage-dependent activation to more
negative membrane voltages [37]. This channel may be
also regulated by GPCRs. One indication for such an
interaction is that both activation of a GPCR and a nerve
growth factor receptor inhibited menthol- and cold-
induced TRPM8 activity [38]. Using temperature sensi-
tivity as a criterion for channel identification may be
more reliable than relying on drug sensitivity due to un-
certainties of drug selectivity. Another reason for asses-
sing changes in thermosensitive TRP channel expression
is that they may underlie sensitivity differences in sen-
sory neurons to cold and mechanical stretch [39]. Such
a possibility has prompted interest in developing drugs
targeting thermosensitive TRP expression since they may
prove to be useful antinociceptives.
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Retina, pigment epithelium and uvea
Retinal TRPV1 gene transcripts and protein expression
have been identified in species ranging from teleosts,
amphibians, birds to mammals. Even though capsaicin is
routinely used to characterize functional TRPV1 expres-
sion, there is uncertainty about its selectivity since it has
side effects. Capsaicin may also activate a TRP melasta-
tin receptor (i.e. TRPM1) described in the retina [40].
However, this is questionable since capsaicin also elicited
current responses in TRPM1−/− mice [41]. A recent re-
port showed that the capsaicin response is eliminated in
mice lacking the mGluR6 receptor. This suggests that
this agonist may also act on either this metabotropic re-
ceptor or its downstream GTP binding protein (G0) het-
eromers [42]. The caveat of sole reliance on capsaicin
effects to identify TRPV1 activity also applies to capsaze-
pine (CPZ), which is commonly used as a TRPV1 antag-
onist. This cautionary note is indicated since CPZ also
has effects in TRPV1−/− mice. These responses include
antagonism of voltage-gated Ca2+ channels, acetylcho-
line receptors, hyperpolarization-activated cation chan-
nels, and stimulation of amiloride-sensitive ENaCs [1].
Another cautionary note is indicated regarding protein
expression since with different antibodies and protocols,
the number of reported bands is inconsistent. This vari-
ability points to the need to validate all results by showing
negative staining in Western blots in fractions obtained
from TRPV1−/− mice. Nevertheless, TRPV1 expression
may be involved in controlling ontogenetic development.
It may regulate the synaptic plasticity during superior col-
liculus development [1]. Despite these uncertainties, max-
imal activation of TRPV1 by capsaicin has been shown to
induce neuronal and glial excitotoxicity in some areas of
the brain and apoptosis in cultured RGCs. Based on some
studies suggesting that TRPV1 is mechanosensitive, Sap-
pington et al. determined if TRPV1 is a target for RGC
death in vivo during exposure to elevated intraocular pres-
sure (IOP). As raising the pressure in an isolation chamber
by 70 mmHg caused increased RGC death, the authors
surmised that elevated intracellular Ca2+ levels were at-
tributable to neurotoxicity caused by TRPV1 hyperactiva-
tion [3]. These data provide an interesting retinal disease
model for RGC remodelling and apoptosis elicited by in-
creases in intracellular Ca2+ levels during exposure to ele-
vated pressures that induce mechanosensitive TRPV1
hyperactivation.
Even though TRPV1 hyperactivation may be deleterious
under some conditions, there are contradicting reports
showing that this change is instead neuroprotective in other
contexts. Specifically, in TRPV1−/− mice, elevated IOP was
more damaging to RGCs when compared to the wildtype
counterparts, suggesting that TRPV1 expression is instead
neuroprotective [6]. Furthermore, in CPZ-treated rats,anterograde retrograde transport of markers were inhib-
ited, which was associated with axonal loss and astroglio-
sis. These findings prompted suggestions that TRPV1
expression is instead neuroprotective during RGC expos-
ure to retinal stress. Taken together, these opposing effects
of alleged changes in TRPV1 activity may be context
dependent.
Various other TRPs are also detected in the mouse ret-
ina (TRPC1-4 TRPM1/3/7, TRPML1, TRPP2, TRPV2,
TRPV4 [43,44]. In mouse RGCs, TRPV4 modulates cal-
cium flux, spiking rate, and apoptosis. Furthermore,
TRPC1 and TRPC4 are expressed in the chicken retina
[45]. TRPM1 is expressed on ON-bipolar cell dendrites
that invaginate photoreceptor terminals and on the
synaptic ribbons of a subclass of rods. This expression
pattern suggests a dual function for TRPM1 in the ON-
pathway [40]. TRPV1, TRPM8 and TRPA1 are expressed
in retinal tumour cells (retinoblastoma). Interestingly,
the expression of TRPA1 was completely suppressed in a
retinoblastoma cell line, which is resistant to the cyto-
static agent etoposide [46]. In addition, TRPV1-4,
TRPM8 and TRPA1 expressions in retinal pigment epi-
thelial (RPE) cells are described in a review describing
ocular tissue specific gene expression patterns [47]. In-
creasing the ambient temperature or insulin-like growth
factor-1 (IGF-1) increased the vascular endothelial
growth factor-A (VEGF-A) secretion rate in RPE cells
indicating that TRPs are involved in the IGF-1 induced
response [48]. Regarding the human uvea, there is only
one study demonstrating gene expressions for TRPV1,
TRPM8 and TRPA1. Notably, in human uveal melanoma
cells, the gene expression of TRPM8 is at a lower level
whereas the TRPA1 expression is at a high level in
healthy uvea [49].
Conjuncitva and limbus
There are functional thermosensitive TRPM8, TRPV1
and TRPV2 as well as TRPV4 expressions in conjunc-
tival epithelial cells [50,51]. Functional TRPM8 expres-
sion is evident based on increases in intracellular Ca2+
levels and currents elicited by icilin that were blocked by
the TRPM8 antagonist, BCTC. Similarly, BCTC also
blocked these increases induced by a thyroxin metabol-
ite, thyronamine (T1AM), indicating that it is an en-
dogenous TRPM8 agonist. TRPM8 activation by either
icilin or T1AM suppressed TRPV1-induced increases in
interleukin 6 (IL-6) expression indicating intracellular
signalling interaction or crosstalk between these TRP
channels. TRPV1 expression is functional since
capsaicin-induced Ca2+ transients, ionic currents and in-
creases in proinflammatory IL-6 release were all blocked
during exposure to CPZ. TRPM8 and TRPV1 coexpres-
sion in these cells as well as on afferent trigeminal oph-
thalmic branch sensory neurons is supportive of the
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maintenance of ocular surface health [52-55]. Cold stimu-
lation of TRPM8 increases in mice lacrimation whereas
TRPV1 activation by noxious agents induces pain and
avoidance behaviour [56,57]. On the other hand, the
TRPV1-induced increase in proinflammatory cytokine re-
lease occurring in dry eye disease (DED) may be moderated
through receptor crosstalk between TRPM8 and TRPV1
[50]. Therefore, it may be advantageous to evaluate the ef-
fectiveness of TRPM8 agonists to increase lacrimation and
reduce TRPV1-induced immune responses.Corneal epithelium
In rats, mice and human corneal epithelia, there are
TRPV1-4 expressions [58-60]. Their presence suggests
that this tissue layer is well poised to counter chal-
lenges to its functional competence caused by expos-
ure to noxious agents, anisosmotic challenges, elevated
temperatures and pathogens. Furthermore, the mito-
genic response to epidermal growth factor receptor
(EGFR) phosphorylation by EGF is dependent on in-
creases in plasma membrane Ca2+ influx elicited by a
SOC composed of TRPC4 subunits. This dependence
is evident since knockdown of TRPC4 expression in
human corneal epithelial cells (HCEC) markedly re-
duced cell proliferation and migration [61]. Con-
versely, another important TRPV1 function is that its
activation by capsaicin induces increases in cell prolif-
eration and migration through transactivating EGFR
[62]. The HCEC mitogenic response to capsaicin is
consistent with a mouse study in which corneal re-
epithelialization following debridement was delayed in
TRPV1−/− knockout mice compared to their wildtype
counterparts. This stimulatory effect of TRPV1 in pro-
moting cell proliferation and migration is associated
with increases in IL-6 and substance P expression,
which are coactivators of growth factor induced wound
healing [58]. TRPV4 expression was identified in intact
human corneal epithelium and its activation by expos-
ure to a hypotonic challenge is required for inducing
regulatory volume decrease behaviour [63]. Further-
more, hypertonic stresses identical to those described
in some dry eye patient tears elicited through TRPV1
channel activation, raised proinflammatory cytokine
levels by eliciting mitogen-activated protein kinase
(MAPK) and nuclear factor-κB (NF-kB) activation
[64,65]. Taken together, corneal epithelial functional
TRP expression contributes to countering anisosmotic
challenges similar to those identified in the tears of
some dry eye patients. Such stress can compromise
maintenance of corneal epithelial barrier function ren-
dering the tissue layers vulnerable to pathogenic infil-
tration and declines in transparency.Corneal stroma
Subsequent to the breaching of the corneal epithelial base-
ment membrane by a severe injury, transforming growth
factor–β (TGFβ) infiltrates into the stroma and activates
its cognate receptor on human fibroblasts also expressing
TRPV1. These two receptors interact through crosstalk to
induce myofibroblast transdifferentiation leading to fibro-
sis and corneal opacification subsequent to a severe injury
[66]. This dependence on TRPV1 activation is evident
since during exposure to CPZ, exogenous TGFβ-1 failed
to elicit increases in α-smooth muscle actin (SMA) ex-
pression. This result is pertinent for efforts to reduce cor-
neal opacification and inflammation following a chemical
burn since it suggests that in a clinical setting treatment, a
TRPV1 antagonist could promote restoration of corneal
transparency by inhibiting TGFβ-induced myofibroblast
transdifferentiation. It is noteworthy that loss of TRPV1
function in two different mouse wound healing models
has opposite effects on restoring transparency during cor-
neal wound healing. In the epithelial layer, wound closure
is delayed due to declines in cell proliferation and migra-
tion whereas in the stroma, fibrosis and inflammation are
suppressed. These polymodal effects of TRPV1 activation
suggest that TRPV1 antagonist usage in a clinical setting
may need to be restricted to cases involving penetrating
stromal injury in which case corneal opacification occurs
due to fibrosis and dysregulated chronic inflammation
[67].
Corneal nerve fibres
TRPA1 and TRPM8 are expressed on corneal afferent
nerves. Corneal nerve fibres are radially distributed
within the stroma and the adjacent limbus [68]. Mouse,
guinea pig and human corneal nerve fibres contain sen-
sory neurons in which TRPV1 and TRPM8 are highly
expressed at levels similar to those in their non-corneal
counterparts [54,55,57] and in non-corneal primary sen-
sory neurons [35]. These channels mediate excitation
and subsequent desensitization to capsaicin (TRPV1) or
menthol (TRPM8). In a clinical context, thermosensitive
TRPM8 function in nerve fibres may be relevant for dry
eye syndrome treatment since corneal cooling below 23°C
increased lacrimation through TRPM8 activation whereas
warming had an opposite effect [57].
Corneal endothelium
Rae and Watsky [69] first described that in the corneal
endothelium, whole-cell configuration of patch-clamp
recordings showed an outwardly rectifying thermosensi-
tive current along with a K+-selective current. The origin
of this thermosensitive component was not identified
but may be attributable to TRP activity [69]. More re-
cently, thermosensitve TRPV1-4 channel activities were
identified in human corneal endothelial cells [70-72].
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still unclear. Thermosensitive TRPM8 was identified in
human corneal endothelial cells based on showing that
application of the super cooling TRPM8 agonist icilin re-
versibly increased intracellular Ca2+. One possible up-
shot of TRPM8 presence in the endothelium is that
preservation of its function in an eye bank setting may be
dependent on its activation during storage at temperatures
below 23°C [73,74]. Such expression may contribute to the
ability of the endothelial cell layer to maintain tissue
homeostasis function over a broader temperature range.
Besides TRPM8 expression in human corneal endothelial
cells, there might also be other TRPs expressed in human
corneal endothelium since H2O2 induced significant in-
crease in [Ca2+] [75]. These limited results indicate that
there remains a large void in our understanding of the
contribution made by functional TRP expression to the
maintenance of corneal transparency and deturgescence.
Lens epithelium
Regarding lens (epithelial) cells, there is very limited infor-
mation on the functional involvement of TRPs. TRPV4 in
porcine lens epithelium regulates hemi-channel-mediated
ATP release and Na+-K+-ATPase activity [76]. In addition,
TRPV1 gene expression was identified in the lens and its
gene expression is at a very high level compared to that in
the retina [77].
TRP channelopathies and ocular disease
TRP gene mutations underlie numerous inherited dis-
eases in humans including the eye. These diseases are
associated with dysfunctional channel expression and
are termed TRP channelopathies [13,14,78]. So far, TRP
channelopathies have been linked to cardiovascular,
renal, skeletal and nervous system pathologies [13]. With
respect to the eye, there are only a few such studies.
One of them deals with mucolipidosis type IV (MLIV). It
is an autosomal recessive, neurodegenerative lysosomal
storage disorder, which is due to mutations in the gene
MCOLN1. MLIV is clinically characterized not only by
ophthalmologic abnormalities such as corneal opacity,
retinal degeneration and strabismus, but also by other non-
ocular abnormalities. MCOLN1 which encodes the protein
mucolipin 1 (MNL1) is a non-specific cation channel
(TRPML1) [79]. In addition, human TRPM1 mutations are
associated with congenital stationary night blindness
(CSNB), whose patients lack rod function and suffer from
night blindness starting in early childhood [80].
Dry eye syndrome
At this point, it is unclear whether there is an associ-
ation between a TRP channelopathy and DED. Neverthe-
less, even without a mutated expression, an altered level
of expression may trigger or promote DED. Based oncurrent evidence, there are indications that either one or
both of the aforementioned changes could contribute to
DED. In DED, ocular surface inflammation and desicca-
tion may stem from dysfunctional TRPV1 and TRPM8
expressions and/or conditions in this disease that pro-
mote their hyperactivations. With regards to TRPV1, it
is activated by hypertonic conditions similar to those
identified in some DED afflicted patients. In vitro, such
levels lead to increases in the expression of the same
proinflammatory cytokines, chemokines and matrix me-
talloproteinases, whose levels are elevated in patient
tears. TRPM8 is also implicated since its expression on
afferent sensory corneal nerves and in the cell layers
contributes to maintenance of basal tear flow during
thermal stress [51,57,64]. Taken together, TRPM8 ago-
nists should be evaluated in various dry eye animal
models to determine if they reduce dry eye symptomol-
ogy and dampen TRPV1-induced inflammation and cor-
neal opacification.
Diabetic retinopathy
In diabetic retinopathy, impaired blood flow due to vascular
occlusion can lead to retinal hypoxia causing photoreceptor
and neuronal cell death and visual impairment. There are
various studies describing a connection between TRPs
and diabetes mellitus [81,82], but none directly relates
to diabetic retinopathy. On the other hand, some are
available pertaining to non-diabetic related retinopathy
(e.g. melanoma-associated retinopathy) [80,83,84].
Glaucoma
One of the pathological events in this insidious disease
includes declines in RGC function due to IOP elevations
compressing nerve fibres traversing through the optic
nerve head. Changes in TRP function may contribute to
changes in RGC function induced by such stress since
they are expressed in this tissue [3,41]. Other tissue
changes that may contribute to glaucoma damage are
obstruction of aqueous outflow pathways through the
trabecular meshwork (TM) and/or a change in ciliary
muscle contractility. References describing TRPC channels
in these tissues are listed in a recent review [45]. As their
activities are sensitive to changes in intracellular Ca2+ con-
tent, they are referred to as SOCs. It has been suggested
that 11 different mechanosensitive TRP channels identified
in trabecular meshwork cells could be activated by in-
creases in IOP and contribute to TM pathology [85].
Therefore, developing selective drug targeting mechano-
sensitive TRP channels may provide a novel option to treat
hypertensive glaucoma.
Cataract
Increase in intracellular Ca2+ level is associated with catar-
actogenesis [86]. TRPV1 immunostaining was identified in
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esis since such an effect induces rises in intracellular
calcium [77]. A possible role is summarized in a review
describing store-operated Ca2+ channels composed of
TRPC subunit expressions (i.e. TRPC1 and TRPC5) in
cataract development [47].
Ocular tumours
Ocular tumour incidence is rarer than in non-ocular
tissues. Choroidal- or corneal tumorigenesis is unique
to ocular tissues because it is not directly related
to tumour neovascularization, which is a dangerous
progression that promotes tumour growth and metas-
tasis. Endothelial cell proliferation drives neovascu-
larization and several different TRP subtypes have
been detected in this tissue. However, there are no
studies yet describing their contribution to tumour
neovascularization.
Uveal melanoma
Uveal melanoma (UM) is a devastating disease. Once
this tumour metastasizes out of the eye into the liver,
lung, bone and skin, patient survival rates are poor. ItTable 1 TRP channel pharmacology and ocular cell type local
TRP channel subtype Compound Concentration Role
TRPC1 -TRPC3 2-APB 100 μM Antagonis
TRPC4 2-APB 100 μM Antagonis
TRPV1 Capsaicin 1 – 20 μM Agonist
TRPV1 Capsazepine 1 – 10 μM Antagonis
TRPV2 2-APB 200 - 400 μM Agonist
TRPV2 Camphor 400 μM Agonist
TRPV3 2-APB 200 μM Agonist
TRPV4 4α-PDD, 5 μM Agonist
TRPV4 GSK 1016790A 5 μM Agonist
TRPM8 Menthol 50 - 500 μM Agonist
TRPM8 Icilin 2 – 60 μM Agonist
TRPM8 Eucalyptol 3000 μM Agonist
TRPM8 BCTC 10 μM Antagonis
TRPA1 Icilin 2 – 60 μM Agonist
1activation by hypertonic challenge.
2activation by hypotonic challenge.
3Mergler et al. (unpublished data).
HCEC = human corneal epithelial cells.
RCEC = rabbit corneal epithelial cells.
HCjEC = human conjunctival epithelial cells.
HCK = human corneal keratocytes (stroma).
HCEC-12 = human corneal endothelial cells.
HCNF = human corneal nerve fibres.
RPE = retinal pigment epithelium.
TM = Trabecular meshwork.is the second most prevalent malignant tumour of me-
lanocytes [87,88]. This disease directly develops from
degenerated melanocytes in the choroid. TRPM1 was
designated as a melanoma metastasis suppressor based
on its expression in normal pigment cells in the skin
and the eye since it was absent in aggressive,
metastasis-competent melanomas [89]. A similar asso-
ciation pertains to TRPA1 because its expression is
lower in human UM cells than in healthy uvea [49].
An inverse relationship was described for TRPM8,
which is expressed at higher levels in most of the inves-
tigated UM cell lines. Furthermore, TRPV1 and the can-
nabinoid receptor 1 (CB1) are functionally expressed
in UM cells. Interestingly, activation of CB1 induced
Ca2+ transients, which were suppressed by the TRP
channel blockers La3+ and CPZ whereas capsaicin-
induced Ca2+ transients could also be suppressed by
CB1 activation. Therefore, it is suggested that identifi-
cation of functional TRPV1, TRPM8, TRPA1 and CB1
expressions in UM may provide novel drug targets for
treatment of this aggressive neoplastic disease. A simi-
lar suggestion was made for treating non-uveal melan-
oma (TRPM8) [90].ization
Expression/localization References
t HCEC Mouse retina TM [43,61,85]
t RCECMouse retina [43,61,93]
HCEC1, HCK HCEC-12 Rat retina HCjEC
Rat and mouse retinas Human retina
(tumour) Uvea (tumour)
[3,41,46,49,59,60,66,71,94]




HCEC-12 HCEC2, HCjEC [46,63,70]
HCEC-12 [70]
HCNF HCEC-12 [54,55,57,72,96]
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Retinoblastoma (RB) is a malignant retinal tumour,
which develops from immature retinal cells. Its inci-
dence is low but is the most common ocular tumour of
the eye in children and is associated with a RB mutation
[91]. There have been only a few reports describing a
TRP’s involvement whereas other types of Ca2+ channels
have been studied more extensively.
Regarding Ca2+ permeable TRPs, Hanano et al. sug-
gested a possible significant regulatory role of TRPM7 for
RB cell proliferation as a spontaneously activated Ca2+ in-
flux pathway [92]. Another study revealed TRPV1, TRPM8
and TRPA1 gene expression in retinoblastoma cells. Not-
ably, the expression of TRPA1 was suppressed in
etoposide-resistant RB cells [46]. Therefore, using genetic
approaches to upregulate TRPA1 expression could provide
a means to induce etoposide sensitivity and suppress RB
cell tumorigenesis.
Furthermore, CB1 receptors could be detected as
shown in uveal melanoma cells. Activation of CB1 sup-
pressed the TRPV1-induced Ca2+ increases in etoposide-
sensitive RB cells whereas this effect did not occur in
etoposide-resistant RB cells. Nevertheless, the limited
TRP characterizations suggest that there are clear differ-
ences between healthy and tumour ocular tissues or
cytostatic-resistant ocular tissue. Therefore, modulation
of TRP expression and/or function could provide a crit-
ically needed therapeutic option. In addition, monitoring
TRP expression levels could provide a prognostic marker
for identifying this insidious disease.Conclusion
Ocular TRP functional expression is essential for medi-
ating both adaptive and maladaptive responses to a wide
variety of different environmental conditions that can
impact tissue homeostasis maintenance. Table 1 summa-
rizes ocular tissue TRP channel subtype localization and
pharmacology described in pertinent references. As
there is an association between aberrant TRP channel
expression and human disease, these regulators of Ca2+
influx may be potential drug targets for usage in a clin-
ical setting. Nevertheless, much effort is still needed to
validate this suggestion.
Firstly, specific sites on TRP channel structure must
be delineated that account for each of the responses me-
diated by selective channel activity modulation. Sec-
ondly, site-specific mutations must be expressed to
determine if such alterations correspond with any of the
pathophysiological responses by cells that express TRP
channels. Finally, drug-induced reversal of any changes
caused by disease must be selective without serious side
effects. For example, even though TRPV1 inhibition by
CPZ can be selective in some settings, this antagonistalso elevates body temperature at the same time that it
reduces an inflammatory response in some tissues. Ac-
cordingly, TRPV1 antagonist development to reduce fi-
brosis and the likelihood of chronic inflammation may
require designing drugs interacting only with specific
domains on TRPV1 channels linked to signalling path-
ways mediating these sight-compromising responses rather
than those eliciting body temperature control. As de-
scribed above, resolving site-specific regions on TRPV1
channels controlling different responses could be bene-
ficial for fine tuning specific responses promoting re-
epithelialization rather than those inducing corneal opacifi-
cation and neovascularization. Judging from the
burgeoning number of publications per year, TRP drug
targeting may yet improve management in a clinical
setting of a of host diseases.
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